Zhang Tao, Zhang Jia-Tao, Li Wen-Feng, Lin Jun-Tao, Liu Si-Yang, Yan Hong-Hong, Yang Jin-Ji, Yang Xue-Ning, Wu Yi-Long, Nie Qiang, Zhong Wen-Zhao
Shantou University Medical College, Shantou 515041, China.
Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital Affiliated with the South China University of Technology and Guangdong Academy of Medical Sciences, Guangdong Key Laboratory of Lung Cancer Translational Medicine, Guangzhou 510080, China.
J Thorac Dis. 2019 Jul;11(7):2754-2762. doi: 10.21037/jtd.2019.06.32.
We aimed to validate the tumor (T) descriptors of visceral pleural invasion (VPI) for T1 tumors (<3 cm) in the 8th edition of the tumor-node-metastasis (TNM) classification system and the prognostic value of VPI for resected T1a tumors.
The external cohort consisted of 23,501 patients with resected pN0 non-small cell lung cancer (NSCLC) selected from the Surveillance, Epidemiology, and End Results (SEER) database (2010 to 2013). The classification of T1 tumors with VPI was investigated using survival curves. The internal cohort consisted of patients diagnosed with pN0 NSCLC between 2011 and 2013 at Guangdong Lung Cancer Institute. The prognostic value of VPI for T1a tumors (<1 cm) was further assessed in these two cohorts.
The overall survival (OS) and lung cancer-specific survival (LCSS) of the T1-VPI group and groups of each T stage (size only) were compared in the external (SEER) cohort. There were no significant survival differences between the T1-VPI and T2a groups (OS: P=0.706; LCSS: P=0.792) and T1-VPI and T2b groups, although the latter showed a trend toward lower P-values (OS: P=0.117; LCSS: P=0.094). In the internal cohort, a significant difference in OS was observed between patients with T1-VPI and those with T2b (P=0.049). Among patients with T1a tumors and VPI in the SEER database, the prognosis of the non-sub-lobectomy group was superior to that of the sub-lobectomy group, with intrathoracic recurrence as the predominant relapse pattern of T1 tumors with VPI (69.2%).
T1 tumors (<3 cm) with VPI can be staged as T2a in the 8th TNM staging system and surgical resection of T1a tumors is a concern when VPI is present.
我们旨在验证肿瘤-淋巴结-转移(TNM)分类系统第8版中T1肿瘤(<3 cm)的脏层胸膜侵犯(VPI)的肿瘤(T)描述符以及VPI对切除的T1a肿瘤的预后价值。
外部队列由从监测、流行病学和最终结果(SEER)数据库(2010年至2013年)中选取的23501例接受切除的pN0非小细胞肺癌(NSCLC)患者组成。使用生存曲线研究伴有VPI的T1肿瘤的分类。内部队列由2011年至2013年在广东省肺癌研究所诊断为pN0 NSCLC的患者组成。在这两个队列中进一步评估VPI对T1a肿瘤(<1 cm)的预后价值。
在外部(SEER)队列中比较了T1-VPI组与每个T分期(仅大小)组的总生存期(OS)和肺癌特异性生存期(LCSS)。T1-VPI组与T2a组(OS:P = 0.706;LCSS:P = 0.792)以及T1-VPI组与T2b组之间的生存率无显著差异,尽管后者的P值有降低趋势(OS:P = 0.117;LCSS:P = 0.094)。在内部队列中,观察到T1-VPI患者与T2b患者的OS有显著差异(P = 0.049)。在SEER数据库中伴有VPI的T1a肿瘤患者中,非肺叶切除术组的预后优于肺叶切除术组,胸内复发是伴有VPI的T1肿瘤的主要复发模式(69.2%)。
在第8版TNM分期系统中,伴有VPI的T1肿瘤(<3 cm)可分期为T2a,当存在VPI时,T1a肿瘤的手术切除是一个需要关注的问题。